These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6358110)

  • 21. [Rheologic properties of the blood in Raynaud's syndrome and disease].
    Kovalenko VI; Baturin LI
    Vestn Khir Im I I Grek; 1983 Aug; 131(8):37-9. PubMed ID: 6649277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal blood viscosity in Raynaud's phenomenon.
    Goyle KB; Dormandy JA
    Lancet; 1976 Jun; 1(7973):1317-8. PubMed ID: 58309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invariability of blood viscosity after cold testing in patients suffering for Raynaud's disease.
    Pola P; Savi L; Dal Lago A; Flore R; Shami J
    J Cardiovasc Surg (Torino); 1980; 21(2):211-4. PubMed ID: 7364865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Raynaud's phenomenon and blood viscosity.
    Ernst E
    Br J Surg; 1981 Jul; 68(7):520. PubMed ID: 7248730
    [No Abstract]   [Full Text] [Related]  

  • 25. [Acute confusion syndrome secondary to hyperviscosity in multiple myeloma].
    Gómez E; Roncero C; de Pablo J; Bladé J
    Med Clin (Barc); 1999 Nov; 113(16):635. PubMed ID: 10609259
    [No Abstract]   [Full Text] [Related]  

  • 26. [50-year-old patient with leukocytoclastic vasculitis and arthralgia].
    Hennecke T; Harlacher R; Kemper R; Neumann R; Kindler J
    Internist (Berl); 1996 Nov; 37(11):1159-62. PubMed ID: 9036112
    [No Abstract]   [Full Text] [Related]  

  • 27. [Myeloma type IgAk, hyperlipidemia and hyperviscosity syndrome].
    Dieuzeide G; Pire R; Simian S
    Medicina (B Aires); 1988; 48(1):54-8. PubMed ID: 3216789
    [No Abstract]   [Full Text] [Related]  

  • 28. [The plasmatic hyperviscosity syndrome].
    Azzena D; Astengo F; Lercari G; Azzolini A
    Clin Ter; 1968 Jul; 46(2):131-8. PubMed ID: 4973952
    [No Abstract]   [Full Text] [Related]  

  • 29. Letter: Abnormal blood viscosity in Raynaud's phenomenon.
    Forconi S; Guerrini M; Agnusdei D; Pasini FL; di Perri T
    Lancet; 1976 Sep; 2(7985):586. PubMed ID: 60674
    [No Abstract]   [Full Text] [Related]  

  • 30. [A case of IgA-kappa multiple myeloma with hyperviscosity syndrome terminating in plasma cell leukemia].
    Kimizu K; Hamada A; Haba T; Kitoh C; Takeshita H; Yamazaki Y; Tokuda T; Misaki H; Kobayashi T; Shimada K; Doishita K; Sugai S; Konishi F
    Rinsho Ketsueki; 1983 May; 24(5):572-9. PubMed ID: 6411949
    [No Abstract]   [Full Text] [Related]  

  • 31. Platelet activation, fibrinolytic activity and circulating immune complexes in Raynaud's phenomenon.
    Kallenberg CG; Vellenga E; Wouda AA; The TH
    J Rheumatol; 1982; 9(6):878-84. PubMed ID: 7161779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperviscosity syndrome in a patient with plasma cell leukemia.
    Douer D; Weinbergerr A; Djaldetti M; Asherov J; Pick I; Pinkhas J
    Acta Haematol; 1979; 62(2):81-5. PubMed ID: 119405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum hyperviscosity syndrome associated with IgG myeloma in a cat--.
    Hribernik TN; Barta O; Gaunt SD; Boudreaux MK
    J Am Vet Med Assoc; 1982 Jul; 181(2):169-70. PubMed ID: 7118700
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasma adrenomedullin and endothelin-1 levels are reduced and Raynaud's phenomenon improved by daily tadalafil administration in male patients with systemic sclerosis.
    Rosato E; Letizia C; Proietti M; Aversa A; Menghi G; Rossi C; Torella E; Cotesta D; Petramala L; Bruzziches R; Spera G; Pisarri S; Salsano F
    J Biol Regul Homeost Agents; 2009; 23(1):23-9. PubMed ID: 19321043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Non-macroglobulinaemic plasma-cell dyscrasia. II. Osseous affectation (author's transl)].
    De Villalobos E; Alvarez Sánchez B; Outeirińo J; Montalban C; García Robledo A; Calleja JL; Ortíz Masllorens F; Sánchez Fayos J
    Sangre (Barc); 1977; 22(5):612-7. PubMed ID: 905939
    [No Abstract]   [Full Text] [Related]  

  • 36. [A case of so-called primary pulmonary hypertension with Raynaud's phenomenon, hypergammaglobulinemia and thrombocytopenia (author's transl)].
    Kashiwazaki S; Yamada N; Shima S; Okada J; Komeji S; Hoshina H; Tazaki Y
    Nihon Naika Gakkai Zasshi; 1978 Feb; 67(2):167-71. PubMed ID: 650044
    [No Abstract]   [Full Text] [Related]  

  • 37. Myelomatosis and the hyperviscosity syndrome.
    Preston FE; Cooke KB; Foster ME; Winfield DA; Lee D
    Br J Haematol; 1978 Apr; 38(4):517-30. PubMed ID: 646950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The hyperviscosity syndrome. I. In IgG myeloma. The role of protein concentration and molecular shape.
    MacKenzie MR; Fudenberg HH; O'Reilly RA
    J Clin Invest; 1970 Jan; 49(1):15-20. PubMed ID: 5409803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperviscosity syndrome in plasma cell dyscrasias.
    Mehta J; Singhal S
    Semin Thromb Hemost; 2003 Oct; 29(5):467-71. PubMed ID: 14631546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases.
    Rychlik-Golema W; Mastej K; Adamiec R
    Int Angiol; 2006 Jun; 25(2):221-7. PubMed ID: 16763543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.